When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TKPHF - IPO Update: Sigilon Therapeutics Aims For $101 Million IPO
Takeda Pharmaceutical Co Ltd
Sigilon Therapeutics has filed proposed terms for its $101 million U.S. IPO.
The firm is advancing programs to treat blood, lysosomal storage and other diseases.
SGTX has produced a positive initial result with its first trial patient, has a strong collaboration relationship with Eli Lilly and the IPO appears reasonably priced.
For life science investors with a patient hold time frame, the IPO is worth considering.